Indeed, gal-3 silencing or overexpression, reduced or increased cleaved Notch-1 intracellular domain (NICD1), respectively, and the expression of the Notch target genes Hes1 and Hey1 in ovarian cancer cells [17]. This evidence concerns the gene LGALS3 and ovarian carcinoma.